It can be seen similar to modern Western medicine trials, where the mutation of certain cancers (KRAS, BRAF, and c-KIT) or the combined positive score (CPS) for immune-checkpoint inhibitors need to be tested. The gene discussed is BRAF; the disease is cancer.